Keyphrases
Post-transplant Lymphoproliferative Disorder
100%
Genomic Profiling
100%
Cell-free DNA (cfDNA)
100%
Epstein-Barr Virus
71%
Copy number Variation
57%
Single nucleotide Variant
57%
Epstein-Barr Virus-positive
42%
Tumor
28%
Variant Burden
28%
Lymphoma
14%
Screening Tool
14%
Response Monitoring
14%
Am(III)
14%
Epigenetic Regulation
14%
Metagenomic Next-generation Sequencing (mNGS)
14%
Invasive Procedures
14%
Highly Effective
14%
Observational Cohort Study
14%
Lactate Dehydrogenase
14%
Tumor Protein p53 (TP53)
14%
Minimally Invasive
14%
Solid Organ Transplantation
14%
Mutated Genes
14%
Stage IV Disease
14%
Epstein-Barr Virus DNA Load
14%
B Cell Signaling
14%
DNA Damage Response
14%
NF-κB Pathway
14%
Low-pass Sequencing
14%
PIM-1
14%
Tet Methylcytosine Dioxygenase 2
14%
KMT2D
14%
ARID1A
14%
Somatic Single nucleotide Variants
14%
IGLL5
14%
Medicine and Dentistry
Epstein Barr Virus
100%
Posttransplant Lymphoproliferative Disease
100%
Cell-Free DNA
100%
Single Nucleotide Polymorphism
55%
Copy Number Variation
44%
Neoplasm
22%
Disease
11%
Somatics
11%
Invasive Procedure
11%
Next Generation Sequencing
11%
Cohort Study
11%
Lactate Dehydrogenase
11%
Solid Organ Transplantation
11%
Virus DNA
11%
B Cell Signaling
11%
Whole Genome Sequencing
11%
DNA Damage Response
11%
Immunology and Microbiology
Transplant Procedure
100%
Epstein Barr Virus
100%
Lymphoproliferative Disorders
100%
Single Nucleotide Polymorphism
55%
Copy Number Variation
44%
Blood Plasma
22%
Epigenetics
11%
Next Generation Sequencing
11%
Solid Organ Transplantation
11%
DNA Virus
11%
DNA Damage Response
11%
Whole Genome Sequencing
11%
B Cell Signaling
11%
Biochemistry, Genetics and Molecular Biology
Epstein Barr Virus
100%
Single-Nucleotide Polymorphism
55%
Copy-Number Variation
44%
B Cell
11%
Cohort Study
11%
Signal Transduction
11%
Epigenetics
11%
Next Generation Sequencing
11%
Lactate Dehydrogenase
11%
Mutated Genes
11%
DNA Damage Response
11%
DNA Virus
11%
Whole Genome Sequencing
11%
PIM1
11%
ARID1A
11%